Search Contract Opportunities

Afirma Thyroid Testing VISN 23

ID: 36C26325Q0681 • Type: Special Notice

Description

This is a Notice of Intent published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source, fixed price indefinite delivery contract, as implemented by FAR 13.106-1(b)(2). It is not a request for competitive quotes. The Department of Veterans Affairs, Network Contracting Office 23 intends to award a sole source, fixed price indefinite delivery contract to Veracyte,Inc,6000 Shoreline Court, Suite 300, South San Francisco, CA 94080. VISN 23 has a requirement for reference laboratory testing for Veracyte Afirma Genomic Sequencing Classifier (GSC) (CPT 81546) and Afirma Xpression Atlas (XA) (CPT 0204U) to provide physicians with a comprehensive solution for a complex landscape in thyroid cancer diagnosis and individualization of care. Veracyte Afirma GSC testing enables physicians to answer multiple clinical questions for their thyroid patients using a single, minimally invasive fine needle aspiration (FNA) sample. VISN 23 laboratories: 1. Fargo VA Health Care System; Fargo, ND 2. VA Black Hills Health Care System, Hot Springs, SD 3. VA Black Hills Health Care System, Fort Meade, SD 4. VA Nebraska-Western Iowa Health Care System, Omaha, NE 5. St. Cloud VA Healthcare System, St. Cloud, MN 6. Sioux Falls VA Health Care System, Sioux Falls, SD 7. Iowa City VA Health Care System, Iowa City, IA 8. Minneapolis VA Health Care System, Minneapolis, MN 9. VA Central Iowa Health Care System, Des Moines, IA Market research revealed that Veracyte,Inc is the only authorized services provider for the needed thyroid testing services. The North American Industry Classification System (NAICS) code for this requirement is 621511 and the service code is Q301. While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The Government understands that Veracyte,Inc is the only vendor that can provide the requested services. However, vendors that believe they can provide the capabilities required to fully meet the Government's requirement may submit information in writing to logan.gahring@va.gov by 11:00AM Central Time on April 18, 2025. Such documentation will be reviewed solely for the purpose of determining whether to conduct the procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Background
The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source, fixed price indefinite delivery contract to Veracyte, Inc. This contract is aimed at fulfilling the requirement for reference laboratory testing services for the Veracyte Afirma Genomic Sequencing Classifier (GSC) and Afirma Xpression Atlas (XA), which are critical for thyroid cancer diagnosis and individualized patient care.

The goal is to provide physicians with a comprehensive solution to address complex clinical questions using minimally invasive fine needle aspiration samples.

Work Details
The contractor will provide reference laboratory testing services for the following:
1. Veracyte Afirma Genomic Sequencing Classifier (GSC) (CPT 81546)
2. Afirma Xpression Atlas (XA) (CPT 0204U)

These services are essential for enabling physicians to answer multiple clinical questions regarding their thyroid patients effectively. The testing will be conducted across various VISN 23 laboratories, including:
- Fargo VA Health Care System, Fargo, ND
- VA Black Hills Health Care System, Hot Springs, SD
- VA Black Hills Health Care System, Fort Meade, SD
- VA Nebraska-Western Iowa Health Care System, Omaha, NE
- St. Cloud VA Healthcare System, St. Cloud, MN
- Sioux Falls VA Health Care System, Sioux Falls, SD
- Iowa City VA Health Care System, Iowa City, IA
- Minneapolis VA Health Care System, Minneapolis, MN
- VA Central Iowa Health Care System, Des Moines, IA

Period of Performance
The specific period of performance has not been detailed in the solicitation; however, it is expected that the contract will be indefinite delivery.

Place of Performance
The contract will be performed at various locations within VISN 23 laboratories across multiple states including North Dakota, South Dakota, Nebraska, Minnesota, and Iowa.

Overview

Response Deadline
April 18, 2025, 12:00 p.m. EDT Past Due
Posted
April 15, 2025, 9:42 a.m. EDT
Set Aside
None
Place of Performance
Not Provided
Source
SAM

Current SBA Size Standard
$41.5 Million
Pricing
Fixed Price
Est. Level of Competition
Sole Source
Vehicle Type
Indefinite Delivery Contract
On 4/15/25 VISN 23: Midwest Health Care Network issued Special Notice 36C26325Q0681 for Afirma Thyroid Testing VISN 23 due 4/18/25.
Primary Contact
Title
Contract Specialist
Name
Logan Gahring   Profile
Phone
(319) 339-7113

Documents

Posted documents for Special Notice 36C26325Q0681

Question & Answer

Incumbent or Similar Awards

Contracts Similar to Special Notice 36C26325Q0681

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice 36C26325Q0681

Similar Active Opportunities

Open contract opportunities similar to Special Notice 36C26325Q0681

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > NETWORK CONTRACT OFFICE 23 (36C263)
FPDS Organization Code
3600-00263
Source Organization Code
100183219
Last Updated
April 15, 2025
Last Updated By
Logan.Gahring@va.gov
Archive Date
May 18, 2025